Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▾	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
TENX	Tenax Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$52.60M	n/a	-54.2%	n/a	-$1.34
TELO	Telomir Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.41M	n/a	-176.1%	n/a	-$0.33
TCRT	Alaunos Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.0K	-$4.18M	n/m	-194.0%	-50.0%	-$2.20
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
SYRE	Spyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$155.20M	n/a	-21.7%	n/a	n/a
SYBX	Synlogic, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$1.00M	n/a	-8.5%	-100.0%	-$0.08
SXTP	60 Degrees Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.01M	-$7.37M	-732.5%	-212.7%	65.5%	-$11.73
SXTC	China SXT Pharmaceuticals, Inc. Manufacturing · Year ended 2026-03-31 · USD	$1.14M	-$6.21M	-545.2%	-20.9%	-34.6%	-$9.13
SVRA	Savara Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$118.84M	n/a	-58.5%	n/a	-$0.53
SVA	Sinovac Biotech Ltd Manufacturing · Year ended 2025-12-31 · USD	$386.01M	-$198.84M	-51.5%	-3.1%	6.8%	-$0.83
SUPN	Supernus Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$718.95M	-$38.55M	-5.4%	-3.6%	8.6%	-$0.68
STTK	Shattuck Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.00M	-$48.81M	n/m	-59.2%	-82.5%	-$0.70
STOK	Stoke Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$184.42M	-$6.88M	-3.7%	-2.0%	404.5%	-$0.12
SRPT	Sarepta Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.20B	-$713.41M	-32.5%	-62.5%	15.6%	-$7.13
SPRY	ARS Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$84.28M	-$171.30M	-203.3%	-149.9%	-5.5%	-$1.74
SPRO	Spero Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$66.80M	$8.57M	12.8%	14.5%	39.2%	$0.15
SPRB	Spruce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$38.97M	n/a	-91.7%	-100.0%	-$50.83
SNGX	Soligenix, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.08M	n/a	-209.4%	n/a	-$2.14
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
SMNR	Semnur Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$160.42M	n/a	n/a	n/a	-$0.78
SMMT	Summit Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.08B	n/a	-163.9%	n/a	-$1.44
SLS	SELLAS Life Sciences Group, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.86M	n/a	-37.9%	n/a	-$0.25
SLN	Silence Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$559.0K	-$88.61M	n/m	-142.2%	-98.7%	-$0.63
SLGL	Sol-Gel Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$19.39M	-$6.13M	-31.6%	-26.9%	68.0%	-$2.19
SKYE	Skye Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$55.92M	n/a	-279.3%	n/a	-$1.41

Rows per page: 2550 100